PERGLIM M-2 is an oral antidiabetic medication used in the management of type 2 diabetes mellitus. It is a combination medicine that helps control blood sugar levels in adults when diet, exercise, and single-drug therapy are not sufficient. PERGLIM M-2 works by improving the body’s response to insulin and helping the pancreas release insulin more effectively. Proper blood sugar control reduces the risk of diabetes-related complications such as nerve damage, kidney problems, and vision changes.

Active Ingredient(s) / Generic Name
Each tablet typically contains:

• Glimepiride 2 mg

• Metformin Hydrochloride (usually 500 mg or 1000 mg depending on formulation strength)

Glimepiride is a sulfonylurea, and Metformin Hydrochloride is a biguanide antidiabetic agent.

Brand name/manufacture/marketer
Brand Name: PERGLIM M-2
Manufactured and marketed by a licensed pharmaceutical company. (Specific manufacturer details should be confirmed on the product packaging.)

Indications / Uses
PERGLIM M-2 is indicated for:

• Management of type 2 diabetes mellitus in adults

• Patients whose blood glucose is not adequately controlled with diet and exercise alone

• Patients requiring combination therapy with glimepiride and metformin

It is typically prescribed as part of a comprehensive diabetes management plan that includes lifestyle modifications.

Storage Instructions
Store below 30°C in a cool, dry place.
Keep away from direct sunlight and moisture.
Keep out of reach of children.
Do not use after the expiry date printed on the packaging.

Disclaimer
This medication should be used strictly under the supervision of a qualified healthcare professional. Do not start, stop, or adjust the dose without medical advice. If you have any questions about this product or your treatment plan, consult your doctor or pharmacist.